Search research articles
Contact Us
Filters
Showing results (1-10 of 124) with videos related to
Page
of 13
Sort By:
Future Oncology (London, England)
|
May 10, 2017
Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10
Michinori Ogura, Bertrand Coiffier, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
Clinical development of CT-P10 and other biosimilar cancer therapeutics
Won Seog Kim, Bertrand Coiffier, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements
Christian Buske, Michinori Ogura, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer
Won Seog Kim, Michinori Ogura, Hyuk-Chan Kwon, et al.
Cancer Research and Treatment
|
December 19, 2015
Irinotecan Combined with Bolus Fluorouracil, Continuous Infusion Fluorouracil, and Low-Dose Leucovorin Every Two Weeks in Patients with Oxaliplatin Pretreated Metastatic Colorectal Cancer
Hyuk Chan Kwon, Sung Hyun Kim, Jae Seok Kim, et al.
Diseases of the Colon and Rectum
|
June 7, 2005
Intensity of tumor budding and its prognostic implications in invasive colon carcinoma
Ki-Jae Park, Hong-Jo Choi, Mee-Sook Roh, et al.
World Journal of Gastroenterology
|
December 12, 2007
Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study
Hyuk-Chan Kwon, Sung Yong Oh, Suee Lee, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 26, 2021
Radiation-Shielding Devices: The Best Combination for Spine Interventional Procedures
Young Seok Ji, Eun Kyul Park, Hyuk Chan Kwon, et al.
Oncotarget
|
December 1, 2016
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Nam Hee Lee, Mikyung Kim, Sung Yong Oh, et al.
Journal of Korean Medical Science
|
October 14, 2003
A case of hypertrophic osteoarthropathy associated with nasopharyngeal carcinoma in a child
Seung Hyun Sohn, Seung Hoon Ryu, Hyuk Chan Kwon, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 124) with videos related to
Sort By:
Page
of 13
Future Oncology (London, England)
|
May 10, 2017
Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10
Michinori Ogura, Bertrand Coiffier, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
Clinical development of CT-P10 and other biosimilar cancer therapeutics
Won Seog Kim, Bertrand Coiffier, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements
Christian Buske, Michinori Ogura, Hyuk-Chan Kwon, et al.
Future Oncology (London, England)
|
May 10, 2017
Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer
Won Seog Kim, Michinori Ogura, Hyuk-Chan Kwon, et al.
Cancer Research and Treatment
|
December 19, 2015
Irinotecan Combined with Bolus Fluorouracil, Continuous Infusion Fluorouracil, and Low-Dose Leucovorin Every Two Weeks in Patients with Oxaliplatin Pretreated Metastatic Colorectal Cancer
Hyuk Chan Kwon, Sung Hyun Kim, Jae Seok Kim, et al.
Diseases of the Colon and Rectum
|
June 7, 2005
Intensity of tumor budding and its prognostic implications in invasive colon carcinoma
Ki-Jae Park, Hong-Jo Choi, Mee-Sook Roh, et al.
World Journal of Gastroenterology
|
December 12, 2007
Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study
Hyuk-Chan Kwon, Sung Yong Oh, Suee Lee, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 26, 2021
Radiation-Shielding Devices: The Best Combination for Spine Interventional Procedures
Young Seok Ji, Eun Kyul Park, Hyuk Chan Kwon, et al.
Oncotarget
|
December 1, 2016
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Nam Hee Lee, Mikyung Kim, Sung Yong Oh, et al.
Journal of Korean Medical Science
|
October 14, 2003
A case of hypertrophic osteoarthropathy associated with nasopharyngeal carcinoma in a child
Seung Hyun Sohn, Seung Hoon Ryu, Hyuk Chan Kwon, et al.
Page
of 13